Use of the Peroxisome Proliferator-Activated Receptor (PPAR) γ Ligand Troglitazone as Treatment for Refractory Breast Cancer: A Phase II Study

✍ Scribed by Harold J. Burstein; George D. Demetri; Elisabetta Mueller; Pasha Sarraf; Bruce M. Spiegelman; Eric P. Winer

• Book ID: 111538664
• Publisher: Springer US
• Year: 2003
• Tongue: English
• Weight: 119 KB
• Volume: 79
• Category: Article
• ISSN: 0167-6806
• DOI: 10.1023/a:1024038127156